Neoplasm Staging

"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Descriptor ID	D009367
MeSH Number(s)	E01.789.625
Concept/Terms	Neoplasm Staging Neoplasm Staging Staging, Neoplasm Tumor Staging Staging, Tumor Cancer Staging Staging, Cancer TNM Staging TNM Staging Staging, TNM TNM Staging System Staging System, TNM Staging Systems, TNM System, TNM Staging Systems, TNM Staging TNM Staging Systems TNM Classification Classification, TNM Classifications, TNM TNM Classifications

Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]
Neoplasm Staging [E01.789.625]

Below are MeSH descriptors whose meaning is related to "Neoplasm Staging".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.

Bar chart showing 351 publications over 28 distinct years, with a maximum of 27 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	2	3
1995	0	1	1
1996	0	1	1
1997	0	6	6
1998	0	5	5
1999	0	4	4
2000	1	5	6
2001	2	8	10
2002	0	9	9
2003	0	8	8
2004	0	10	10
2005	2	11	13
2006	0	12	12
2007	0	16	16
2008	1	21	22
2009	4	17	21
2010	0	18	18
2011	0	25	25
2012	0	13	13
2013	1	25	26
2014	1	25	26
2015	1	17	18
2016	1	26	27
2017	0	18	18
2018	0	7	7
2019	3	8	11
2020	1	8	9
2021	0	6	6

Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.

LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, da Costa AABA, Crim AK, Rauh-Hain A, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol. 2022 04; 165(1):82-89.

View in: PubMed
duPont NC, Enserro D, Brady MF, Moxley K, Walker JL, Cosgrove C, Bixel K, Tewari KS, Thaker P, Wahner Hendrickson AE, Rubin S, Fujiwara K, Casey AC, Soper J, Burger RA, Monk BJ. Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2022 02; 164(2):398-405.

View in: PubMed
Wang H, Ding D, Qin T, Zhang H, Liu J, Zhao J, Wu CH, Javed A, Wolfgang C, Guo S, Chen Q, Zhao W, Shi W, Zhu F, Guo X, Li X, Peng F, He R, Xu S, Jin J, Wu Y, Nuer A, Edil B, Tien YW, Jin G, Zheng L, He J, Liu J, Liu Y, Wang M, Qin R. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors. HPB (Oxford). 2022 05; 24(5):681-690.

View in: PubMed
Vergote I, Ray-Coquard I, Anderson DM, Cantuaria G, Colombo N, Garnier-Tixidre C, Gilbert L, Harter P, Hettle R, Lorusso D, Mäenpää J, Marth C, Matsumoto K, Ouwens M, Poveda A, Raspagliesi F, Rhodes K, Rubio Pérez MJ, Shapira-Frommer R, Shikama A, Sikorska M, Moore K, DiSilvestro P. Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer. Eur J Cancer. 2021 11; 157:415-423.

View in: PubMed
Oonk MHM, Slomovitz B, Baldwin PJW, van Doorn HC, van der Velden J, de Hullu JA, Gaarenstroom KN, Slangen BFM, Vergote I, Brännström M, van Dorst EBL, van Driel WJ, Hermans RH, Nunns D, Widschwendter M, Nugent D, Holland CM, Sharma A, DiSilvestro PA, Mannel R, Boll D, Cibula D, Covens A, Provencher D, Runnebaum IB, Luesley D, Ellis P, Duncan TJ, Tjiong MY, Cruickshank DJ, Kjølhede P, Levenback CF, Bouda J, Kieser KE, Palle C, Spirtos NM, O'Malley DM, Leitao MM, Geller MA, Dhar K, Asher V, Tamussino K, Tobias DH, Borgfeldt C, Lea JS, Bailey J, Lood M, Eyjolfsdottir B, Attard-Montalto S, Tewari KS, Manchanda R, Jensen PT, Persson P, Van Le L, Putter H, de Bock GH, Monk BJ, Creutzberg CL, van der Zee AGJ. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. J Clin Oncol. 2021 11 10; 39(32):3623-3632.

View in: PubMed
Nguyen ML, Mohammad-Zadeh A, Krempl G, Razaq M, Collins L, Zahoor T, Zhao D, Henson C. Merkel cell carcinoma: treatment and outcomes over a 10-year period at a high-volume academic center. Int J Dermatol. 2022 May; 61(5):558-563.

View in: PubMed
Wang M, Ding D, Qin T, Wang H, Liu Y, Liu J, Liu J, Zhang H, Zhao J, Wu CH, Javed A, Wolfgang C, Guo S, Chen Q, Zhao W, Shi W, Zhu F, Guo X, Li X, He R, Xu S, Edil B, Tien YW, Jin G, Zheng L, He J, Qin R. New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []. Cancer Lett. 2021 10 10; 518:207-213.

View in: PubMed
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 09; 162(3):532-538.

View in: PubMed
Wang J, Xiu J, Baca Y, Battaglin F, Arai H, Kawanishi N, Soni S, Zhang W, Millstein J, Salhia B, Goldberg RM, Philip PA, Seeber A, Hwang JJ, Shields AF, Marshall JL, Astsaturov I, Craig Lockhart A, Gatalica Z, Michael Korn W, Lenz HJ. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer. Oncogene. 2021 07; 40(30):4894-4905.

View in: PubMed
Moore KN, Bookman M, Sehouli J, Miller A, Anderson C, Scambia G, Myers T, Taskiran C, Robison K, Mäenpää J, Willmott L, Colombo N, Thomes-Pepin J, Liontos M, Gold MA, Garcia Y, Sharma SK, Darus CJ, Aghajanian C, Okamoto A, Wu X, Safin R, Wu F, Molinero L, Maiya V, Khor VK, Lin YG, Pignata S. Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). J Clin Oncol. 2021 06 10; 39(17):1842-1855.

View in: PubMed

People

Explore

Similar Concepts

Top Journals